Abstract, Snapshot, Market Analysis & Market Definition: Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is a drug used to block degradation of cgmp-specific phosphodiesterase type 5 (PDE5) loop GMP in smooth muscle cell lining supplying blood vessels to various tissues. These drugs dilate the cavernous penis, promote erections with sexual stimulation, and are used to treat erectile dysfunction (ED). Sildenafil is the first effective oral therapy for ED. Because PDE5 is also present in the wall of the smooth muscle arterioles of the inner lung, sildenafil and tadalafil dilate these vessels and are FDA approved for the treatment of pulmonary hypertension. In 2018, the global Phosphodiesterase Type 5 (PDE5) Inhibitor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Phosphodiesterase Type 5 (PDE5) Inhibitor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Phosphodiesterase Type 5 (PDE5) Inhibitor development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Sildenafil
Tadalafil
Avanafil
Vardenafil
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hospital
Retail Pharmacy
Online Pharmacies
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Eli Lilly
Pfizer
Bayer
Novartis AG
Merck
GlaxoSmithKline plc
Roche
AstraZeneca
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
Vectura Group
Key Insights Covered: Exhaustive Phosphodiesterase Type 5 (PDE5) Inhibitor Market
1. Market size (sales, revenue and growth rate) of Phosphodiesterase Type 5 (PDE5) Inhibitor industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Phosphodiesterase Type 5 (PDE5) Inhibitor industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Phosphodiesterase Type 5 (PDE5) Inhibitor industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Phosphodiesterase Type 5 (PDE5) Inhibitor industry.
Research Methodology: Phosphodiesterase Type 5 (PDE5) Inhibitor Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.